Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -116.94 | -286.20 | -652.51 | 275.44 |
Depreciation/ Depletion | 220.68 | 243.25 | 233.01 | 206.29 |
Non- Cash Items | 651.84 | 457.51 | 349.26 | 170.97 |
Changesin Working Capital | -54.65 | -370.49 | -187.58 | -171.26 |
Cashfrom Operating Activities | 700.93 | 44.07 | -257.82 | 481.44 |
Capital Expenditures | -118.15 | -94.94 | -143.38 | -297.48 |
Other Investing Cash Flow Items Total | -32.10 | 397.41 | 24.65 | -223.34 |
Cashfrom Investing Activities | -150.25 | 302.47 | -118.73 | -520.82 |
Financing Cash Flow Items | -292.19 | -224.21 | -153.80 | -139.39 |
Total Cash Dividends Paid | -13.52 | 0.00 | -22.43 | -17.92 |
Issuance( Retirement)of Stock Net | 52.67 | 38.47 | 3.62 | 3.67 |
Issuance( Retirement)of Debt Net | -440.29 | -28.18 | 593.92 | 137.84 |
Cashfrom Financing Activities | -693.32 | -213.92 | 421.32 | -15.80 |
Foreign Exchange Effects | 0.16 | 0.15 | 0.13 | -1.22 |
Net Changein Cash | -142.48 | 132.77 | 44.90 | -56.40 |
Cash Interest Paid | 292.19 | 224.21 | 153.80 | 139.39 |
Cash Taxes Paid | -24.25 | -87.65 | -2.33 | -156.80 |
Strides Pharma Science Dividend Strides Pharma Science Bonus Strides Pharma Science News Strides Pharma Science AGM Strides Pharma Science Rights Strides Pharma Science Splits Strides Pharma Science Board Meetings Strides Pharma Science Key Metrics Strides Pharma Science Shareholdings Strides Pharma Science Profit Loss Strides Pharma Science Balance Sheet Strides Pharma Science Q1 Results Strides Pharma Science Q2 Results Strides Pharma Science Q3 Results Strides Pharma Science Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks